CTOs on the Move


 
Health for health. This describes Zilis. We are building the world`s finest health and wellness brand. Our expert team` headed by Derrick DeSilva` M.D.` brings the latest science to our Ambassadors and customers. We are also founded on the belief that all children deserve adequate nutrition. With every sale` we provide life saving nutrition to children in developing countries.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.zilis.com
  • 415 US Highway 377 Street 2020
    Argyle, TX USA 76226
  • Phone: 214.705.3702

Executives

Name Title Contact Details

Similar Companies

TechHealth

TechHealth is a Tampa, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AristaCare at Cedar Oaks

AristaCare at Cedar Oaks is a South Plainfield, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CarePayment

Out-of-pocket healthcare expenses are on the rise, which means patients are having difficulty paying their share and providers are finding it difficult to collect from those patients. It`s a lose-lose situation. CarePayment offers a unique solution that helps patients meet their financial obligations and protect their financial health while helping providers stay financially healthy by reducing bad debt and improving cash flow.

Integra group

Integra group is a Cincinnati, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Foghorn Therapeutics

More than 20,000 genes make us human. Genes control critical aspects of health and disease — but what controls our genes? Foghorn® Therapeutics ($FHTX) is developing therapies based on a system that directs which genes our cells express, and when, where, and in what order. By manipulating this system with our unique Gene Traffic Control™ platform, Foghorn will change how genes turn “on” and “off.” Unlike approaches that edit genes, this novel way of thinking will alter what our DNA has in store for us—and rewrite destiny for millions of people living with disease. With Gene Traffic Control™ Foghorn is pioneering a new, major class of drug targets to develop unprecedented therapies for cancer and other serious diseases. We have already validated multiple targets, are in the process of developing drug candidates in multiple types of cancer and are beginning to explore other diseases.